Appeals court overturns ruling in Axonics-Medtronic neurostim patent dispute

The court said the patent board’s “refusal to consider the new arguments and evidence was erroneous.”

Wesana Health Announces Restructuring of Promissory Note Receivable | Psychedelic Invest

Wesana Health Holdings Inc. (CSE: WESA.X) (OTCQB: WSNAF) (the “Company“), announced the execution of a Confidential Settlement and Release Agreement (“Settlement Agreement”) between Wesana Health Clinics Corp.

November 29, 2023

Preventing the weaponization of AI-designed proteins

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Today, we talk about

March 11, 2024

Pharmalittle: We’re reading about Pfizer and its activist investor, Medicare costs for obesity drugs, and more

Good morning, everyone, and welcome to the middle of the week. Congratulations on making it this far, and remember there are only a few more

October 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.